基于VEGFR靶点的小分子肿瘤靶向抑制肽的<sup>99</sup>Tc<sup>m</sup>标记及鉴定

冯世斌; 李前伟; 郑磊; 邹凌云; 查林; 任浩; 黄定德

您当前的位置：

首页 >

文章列表页 >

基于VEGFR靶点的小分子肿瘤靶向抑制肽的⁹⁹Tc^m标记及鉴定

论著 | 更新时间：2026-01-09

- 基于VEGFR靶点的小分子肿瘤靶向抑制肽的⁹⁹Tc^m标记及鉴定
- Radionuclide labeling of small molecular inhibitory peptides targeting VEGF receptor
- 陆军军医大学学报 2012年34卷第1期页码：24-28
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R394-33;R341;R817
- 纸质出版：2012
- 稿件说明：
移动端阅览
冯世斌,李前伟,郑磊,邹凌云,查林,任浩,黄定德.基于VEGFR靶点的小分子肿瘤靶向抑制肽的99Tcm标记及鉴定[J].陆军军医大学学报(原第三军医大学学报),2012,34(01):24-28.

　Feng Shibin,Li Qianwei,Zheng Lei,Zou Lingyun,Zha Lin,Ren Hao,Huang Dingde.Radionuclide labeling of small molecular inhibitory peptides targeting VEGF receptor[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(01):24-28.
冯世斌,李前伟,郑磊,邹凌云,查林,任浩,黄定德.基于VEGFR靶点的小分子肿瘤靶向抑制肽的99Tcm标记及鉴定[J].陆军军医大学学报(原第三军医大学学报),2012,34(01):24-28. DOI：

　Feng Shibin,Li Qianwei,Zheng Lei,Zou Lingyun,Zha Lin,Ren Hao,Huang Dingde.Radionuclide labeling of small molecular inhibitory peptides targeting VEGF receptor[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(01):24-28. DOI：

摘要

目的探讨基于血管内皮生长因子受体（vascular endothelial growth factor receptor，VEGFR）靶点的小分子肿瘤靶向抑制肽理想的放射性核素

标记方法。方法多肽QKRKRKKSRKKH、RKRKRKKSRYIVLS分别经双功能螯合剂S-acetyl-MAG

、GA(D)GG、HYNIC修饰后进行放射性核素

标记，HPLC及纸层析法鉴定其标记率及放化纯度，

H-TdR 参入实验鉴定其抑制细胞增殖的能力，体外受体竞争结合实验鉴定其受体结合活性。结果以HYNIC为双功能螯合剂，这2条多肽的

标记率分别为（94.13±1.77）%、（93.79±3.53）%，明显高于S-acetyl-MAG

、GA(D)GG修饰多肽的标记率。经HYNIC修饰后的多肽对肿瘤细胞A549增殖的抑制率约为（32.86±3.36）%、（61.50±4.50）%，与修饰前无明显变化(P0.05)；多肽标记后仍保持了良好的VEGFR结合活性，室温下放置24 h后，放化纯度仍高达90%左右。结论以HYNIC为双功能螯合剂，以TPPTS为协同配体及还原剂，多肽QKRKRKKSRKKH、RKRKRKKSRYIVLS的

标记率高，且仍具有良好的抑制肿瘤细胞增殖的能力和VEGFR结合活性。

Abstract

Objective To investigate radionuclide labeling methods of small molecular inhibitory peptide targeting vascular endothelial growth factor receptor (VEGF receptor) of tumor with

. Methods After being modified by S-acetyl-MAG

GA(D)GG and HYNIC respectively

QKRKRKKSRKKH and RKRKRKKSRYIVLS were labeled

with

. Labeling efficiency and radiochemical purity was identified by paper chromatography and HPLC. The inhibitory affect of peptide to tumor cell was testified by

H-TdR incorporation. Receptor competition binding assay was used to testify the affinity of peptide ligand based on A549 cells. Results The labeling efficiency of two peptide modified by three bifunctional chelating agents was about 78%

40% and 94% respectively. The inhibitory efficiency of HYNIC-QKRKRKKSRKKH and HYNIC-RKRKRKK-SRYIVLS to A549 cells was about (32.86±3.36)% and （61.50±4.50）%

and did not have statistically significant difference with QKRKRKKSRKKH and RKRKRKKSRYIVLS. Meanwhile the

-HYNIC-QKRKRKKSRKKH and

-HYNIC-RKRKRKKSRYIVLS retained a good stability and binding activity of VEGF receptor in A549 cells. Conclusion HYNIC-QKRKRKKSRKKH and HYNIC-RKRKRKKSRYIVLS have a high labeling efficiency with TPPTS as a reducing agent and collaborative ligand

and the labeled agents retain inhibiting activity and binding activity of receptor to A549 cells.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

脂氧素抑制关节炎大鼠滑膜及IL-1β刺激的RSC-364细胞中VEGF的表达

通脉糖眼明胶囊对糖尿病视网膜病变患者血管内皮生长因子水平的影响

RhoC-siRNA联合Rapamycin抑制人肝癌细胞Bel7402 VEGF表达

参芪降糖颗粒对早期糖尿病肾病患者血清TGF-β1、VEGF的影响

VEGF、HIF-1α在子宫内膜异位症中的表达及意义

基于VEGFR靶点的小分子肿瘤靶向抑制肽的99Tcm标记及鉴定

Radionuclide labeling of small molecular inhibitory peptides targeting VEGF receptor

DOI：

摘要

Abstract

关键词

Keywords

references

基于VEGFR靶点的小分子肿瘤靶向抑制肽的⁹⁹Tc^m标记及鉴定